A clinical evaluation of Nityavirechanakarma (By Aragwadh Phalamajja) treated with Navkarshikaguggulu in the management of Sheetapitta (urticaria)

Phase 2/3

Completed

• Conditions: Dermatographic urticaria. Ayurveda Condition: SITAPITTAM,

• Registration Number: CTRI/2023/08/055953
• Lead Sponsor: Government Akhandanand Ayurveda college

Brief Summary

According to Ayurveda Due to excessive use of Asatmya and ViruddhaAahara nowadays Sheetapitta became most common. Prevalence of Urticaria is about 8.8–20% of individuals in the community experience an attack of urticaria at least once in their lifetime.In modern science it is being cured by antihistamines, corticosteroids, and immunotherapy, which can produce adverse effects on the body. In Ayurveda very few research works have been done on Sheetapitta. Skin disorder is not always painful to the body but it generates pain in the mind of a person who is suffering. Every individual tries to maintain his dignity in the society but along with skin problem individual feels embarrassed in every social activity. For such people, Ayurveda is one of the authentic sciences which creates hope for the betterment.Here the study is selected to find out simple, sure and effective medicament for Sheetapitta which have least or no side effect. For this purpose, Nityavirechanakarma with navakarshikguggulu selected as trial and only Navakarshikguggulu from as standard drug mentioned for Sheetapitta from BhavprakashNighantu.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-08
• Last Update Posted: 2023-07-13
• Study Completion: 2024-05-14

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patient having minimum two classical signs and symptoms of Sheetapitta like varatidashtasansthan vat shoth, Kandu.

Exclusion Criteria

• Patient having age less then 18years and more than 60years will be excluded.
• Disease like, Angio edema, Diabetes mellitus, T.B.infection, Myocardial infarction, Congestive cardiac failure, various kind of Leprosy, AIDS and other systemic disorders that may lead fatal condition will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The efficacy of treatment will be assessed on the basis of the diagnostic criteria.	Follow up will be taken after the completion of treatment for every week up to 2 weeks
varatidashtasansthanvat shoth,kandu,toda,chardi,vidah	Follow up will be taken after the completion of treatment for every week up to 2 weeks

Secondary Outcome Measures

Name	Time	Method
Patient will be assessed on the basis of Vartidashtasansthanvatshoth,kandu,toda,chardi,jwara,vidaha	follow uo will bw taken after the completion of treatment for every week up to 2 weeks

Trial Locations

Locations (1)

Government akhandanand ayurveda college and hospital; 🇮🇳 Ahmadabad, GUJARAT, India

Government akhandanand ayurveda college and hospital

🇮🇳Ahmadabad, GUJARAT, India

Sanjay B Hadiya

Principal investigator

6355696981

sanjuhadiya8541@gmail.com